Phase 2 Clinical trials
Filters
Sort by
- All
- Additive Manufacturing
- B2B Procurement Solution
- Clean Energy / Technology
- Consumers
- Contingent Worker Services
- Digital Media
- Finance and Property
- Governance
- Healthcare / Life Sciences / Medical Devices
- Infrastructure and Manufacturing
- Logistics
- Marketplace
- Materials
- Other
- Packaging
- Resources & Mining
- Security
- Small Cap
- Social Network
- Supply Chain Management
- Technology
- Terahertz
- All
- ASX Listed
- Capitalisation of CEF (closed-end crypto index fund) via ICO
- Clinical Development
- Commercialisation
- Commercialised
- Early Stage
- Exploration
- Fund
- Growth Stage
- ICO
- Investment Manager
- IPO
- Late clinical stage
- Listed
- Mature Stage
- Phase 2 Clinical trials
- Phase 2 Trials
- Pre Clinical Stage
- Pre-ICO
- Pre-IPO
- Pre-Registration
- Pre-Series A
- Project Financing
- Public Unlisted
- Ready to go to market
- Research and Development
- Seed Capital
- Series A
- Series B
- SGX Listed
- Singaporean
- Start Up
- Startup
Immutep Limited (ASX: IMM)
Healthcare / Life Sciences / Medical Devices / Biotech / Pharmaceuticals Immutep is a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, with operations in Europe, Australia, and the U.S. Immutep is the…
Imugene Ltd (ASX: IMU)
Biomedical / Biotechnology / Biotech Imugene is a clinical stage immuno-oncology company. Its lead product is HER-Vaxx, a B Cell peptide vaccine for the treatment of gastric cancer. The company…
Prescient Therapeutics (ASX: PTX)
Healthcare / Life Sciences / Medical Devices / Biotech / Pharmaceuticals Prescient Therapeutics is a clinical stage oncology company developing targeted therapies that address specific mutations that drive cancer and contribute to resistance. Prescient’s lead drug…
Dimerix Limited (ASX:DXB)
Healthcare / Life Sciences / Medical Devices / Biomedical / Biotechnology / Biotech Dimerix Limited (ASX: DXB) is a clinical-stage drug development company discovering and developing new therapeutic treatments identified using its proprietary drug discovery platform. Our lead…
Loading...